Detalles de la búsqueda
1.
Comparison of case-based learning and traditional method in teaching postgraduate students of medical oncology.
Med Teach
; 41(10): 1124-1128, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31215320
2.
Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study.
Int Immunopharmacol
; 125(Pt B): 111147, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37956490
3.
Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial.
BioDrugs
; 37(2): 259-269, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802320
4.
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Lung Cancer
; 180: 107194, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163774
5.
Influence of concomitant gastric acid suppressants use on the survival of patients with non-small cell lung cancer treated with programmed death-1/ligand-1 inhibitors: A meta-analysis.
Int Immunopharmacol
; 110: 108955, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35750017
6.
Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer.
Future Sci OA
; 8(5): FSO798, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35662746
7.
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study.
J Thorac Oncol
; 17(11): 1306-1317, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049654
8.
Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial.
Cancer Biol Med
; 2021 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33710815
9.
Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study.
J Thorac Oncol
; 16(12): 2109-2120, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358724
10.
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.
Cancer Commun (Lond)
; 41(9): 889-903, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184418
11.
The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis.
Ann Palliat Med
; 9(6): 4081-4088, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33302668
12.
Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Cancer Biother Radiopharm
; 35(5): 362-370, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380843
13.
The expression and the role of PIWI like RNA-mediated gene silencing 3 (PIWIL3) in lung cell line.
Transl Cancer Res
; 9(1): 271-279, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117181
14.
Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study.
Clin Cancer Res
; 26(24): 6445-6452, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046518
15.
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11).
J Thorac Oncol
; 15(10): 1636-1646, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32781263
16.
Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma.
Oncol Lett
; 18(2): 1548-1556, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31423222
17.
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review.
Onco Targets Ther
; 11: 883-890, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29497319
18.
Survival analysis of patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi-center retrospective study.
Thorac Cancer
; 9(2): 278-283, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266865
19.
Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.
Asia Pac J Clin Oncol
; 13(5): e528-e530, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028915
20.
Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro.
Exp Ther Med
; 11(5): 1700-1706, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27168791